MYA
GILD icon

Meiji Yasuda America’s Gilead Sciences GILD Stock Holding History

Meiji Yasuda America’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.31M Buy
41,998
+11,544
+38% +$1.52M 0.89% 36
2026
Q1 		$4.24M Buy
30,454
+5,520
+22% +$773K 1.05% 32
2025
Q4 		$3.06M Buy
+24,934
New +$3.03M 0.7% 47

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Meiji Yasuda America's GILD Position: Q2 2026 in Review

Meiji Yasuda America increased its Gilead Sciences (GILD) stake by 38% in Q2 2026, buying an estimated $1.52M and bringing the position to 41,998 shares worth $5.31M. The position accounts for 0.89% of the portfolio, ranked #36.

Meiji Yasuda America first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. 2,273 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Meiji Yasuda America held 41,998 shares of Gilead Sciences worth $5.31M as of Q2 2026.
  • Meiji Yasuda America bought 11,544 Gilead Sciences shares in Q2 2026, an estimated $1.52M.
  • Gilead Sciences made up 0.89% of Meiji Yasuda America's portfolio in Q2 2026, its #36 holding.
  • Meiji Yasuda America first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • 2,273 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Meiji Yasuda America's 13F filing for Q2 2026, filed 28 Jul 2026.